Drug Profile
Research programme: familial dysautonomia therapeutic lentivirus - Americal Gene Technologies
Alternative Names: AG IKAP; AG-IKAP - Familial dysautonomia therapeutic lentivirusLatest Information Update: 13 Sep 2023
Price :
$50
*
At a glance
- Originator American Gene Technologies International
- Developer American Gene Technologies International; Montana State University
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Peripheral nervous system diseases